Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

February 15, 2005 (Vol. 25, No. 4)

Manufacturing Biologicals Effectively

Bioprocessing Solutions Debated at the Downstream Technology Forum

  • Increasing cost pressures on the biotech industry, in particular, mean that scaleup doggedly remains a major stumbling block in bioprocess manufacturing. "Because of the high risks of clinical failure, large-scale process trials are often done late when there is little time left for iteration," says Nigel Titchener-Hooker Ph.D., ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.